RGS4.md
... ...
@@ -18,14 +18,8 @@ nocite: |
18 18
19 19
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
20 20
21
-|Entity|source |frequency (%)|
22
-|:------:|:----:|:----:|
23
-|BL|GAMBL Exome |0.575 |
24
-|DLBCL|GAMBL Exome |0.108 |
25
-|DLBCL|GAMBL Genome |0.752 |
26
-|FL|GAMBL Exome |0.287 |
27
-|MCL|GAMBL Genome |1.17 |
28
-
21
+### MCL
22
+[[include:MCL_RGS4]]
29 23
30 24
[[include:tables/mermaid_RGS4.md]]
31 25
ROBO2.md
... ...
@@ -14,9 +14,8 @@ nocite: |
14 14
15 15
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
16 16
17
-|Entity|source |frequency (%)|
18
-|:------:|:-------------:|:-------------:|
19
-|MCL |GAMBL genomes|1.9 |
17
+### MCL
18
+[[include:MCL_ROBO2]]
20 19
21 20
## Mutation pattern and selective pressure estimates
22 21
SALL3.md
... ...
@@ -19,12 +19,12 @@ nocite: |
19 19
20 20
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
21 21
22
-|Entity|source |frequency (%)|
23
-|:------:|:---------------------:|:-------------:|
24
-|BL |GAMBL genomes+capture|4.16 |
25
-|BL |Thomas cohort | NA |
26
-|BL |Panea cohort | NA |
27
-|MCL |GAMBL genomes |0.95 |
22
+### BL
23
+
24
+[[include:tables/BL_SALL3]]
25
+
26
+### MCL
27
+[[include:tables/MCL_SALL3]
28 28
29 29
## Mutation pattern and selective pressure estimates
30 30
SI.md
... ...
@@ -14,9 +14,9 @@ nocite: |
14 14
15 15
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
16 16
17
-|Entity|source |frequency (%)|
18
-|:------:|:-------------:|:-------------:|
19
-|MCL |GAMBL genomes|1.42 |
17
+### MCL
18
+[[include:tables/SI]]
19
+
20 20
21 21
## Mutation pattern and selective pressure estimates
22 22